CBUS
Cibus, Inc. (NASDAQ)
Healthcare — Biotechnology
Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-throughput gene-editing system marketed under the Trait Machine brand name. The company was formerly known as Calyxt, Inc. and changed its name to Cibus, Inc. in June 2023. Cibus, Inc. was incorporated in 2010 and is headquartered in San Diego, California.
Price History
Fundamentals
| Market Cap | $114.98M |
| P/E Ratio (TTM) | - |
| Forward P/E | -2.25 |
| EPS (TTM) | $-1.77 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | 62.60% |
| ROE | -190.12% |
| Debt/Equity | 778.33 |
| Recommendation | None |
| Analyst Target | $14.67 |
| Analysts | 3 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 68.3 |
| Beta | 1.65 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $4.19 |
| 52-Week Low | $1.09 |
| 50-Day Avg | $1.39 |
| 200-Day Avg | $1.79 |
| Avg Volume | 394.1K |
| Volume | 121.6K |
Performance Analysis
BULLISHCBUS shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:02 UTC
Back to Screener Export Report